Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223) a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew Smith Chris Parker; Fred Saad; Kurt Miller; Bertrand Tombal; Quan Sing Ng; Martin Boegemann; Vsevolod Matveev; Josep Maria Piulats; Luis Eduardo Zucca; William Carlos Nahas
Lancet oncology v. 20, n. 3, p. 408-419, 2019New York 2019
Acesso online. A biblioteca também possui exemplares impressos.